Literature DB >> 22886595

Allostasis in nonalcoholic fatty liver disease: implications for risk assessment.

György Baffy1.   

Abstract

Allostasis, a concept of anticipatory physiological regulation in response to external and internal challenges, was originally developed in the context of neuroendocrinology and behavioral medicine. Allostasis preserves function under changing conditions by abandoning physiological set points and developing new ones. Allostatic load refers to the aggregate effect of adaptation throughout life, and corresponds to the wear and tear associated with this process. In response to chronic stress, allostatic load may accumulate faster than expected if sustained activation of regulatory systems exceeds optimum operating ranges; this results in increased risk of disease. Used in a broader sense, the allostatic model of adaptive responses, trade-offs, feed-forward cycles, and collateral damage provides a framework for assessing the involvement of environmental-genetic interactions and co-morbidities in the course of chronic disease and developing a comprehensive score for personalized risk prediction. The utility of this approach is illustrated for nonalcoholic fatty liver disease, a prevalent condition with common and less common outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22886595     DOI: 10.1007/s10620-012-2344-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  47 in total

Review 1.  Maternal obesity, metabolic disease, and allostatic load.

Authors:  Michael L Power; Jay Schulkin
Journal:  Physiol Behav       Date:  2011-09-14

2.  Cumulative biological risk and socio-economic differences in mortality: MacArthur studies of successful aging.

Authors:  Teresa E Seeman; Eileen Crimmins; Mei-Hua Huang; Burton Singer; Alexander Bucur; Tara Gruenewald; Lisa F Berkman; David B Reuben
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

Review 3.  Regulation of lipid droplets by autophagy.

Authors:  Hanqing Dong; Mark J Czaja
Journal:  Trends Endocrinol Metab       Date:  2011-03-16       Impact factor: 12.015

4.  The general adaptation syndrome and the diseases of adaptation.

Authors:  H SELYE
Journal:  J Clin Endocrinol Metab       Date:  1946-02       Impact factor: 5.958

5.  Systems biology and the future of medicine.

Authors:  Joseph Loscalzo; Albert-Laszlo Barabasi
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011-02-24

Review 6.  Allostasis: a model of predictive regulation.

Authors:  Peter Sterling
Journal:  Physiol Behav       Date:  2011-06-12

Review 7.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

Review 8.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective.

Authors:  Sam Virtue; Antonio Vidal-Puig
Journal:  Biochim Biophys Acta       Date:  2010-01-06

9.  Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.

Authors:  Tsuguhito Ota; Constance Gayet; Henry N Ginsberg
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

10.  Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.

Authors:  Joseph Loscalzo; Isaac Kohane; Albert-Laszlo Barabasi
Journal:  Mol Syst Biol       Date:  2007-07-10       Impact factor: 11.429

View more
  2 in total

1.  Elevated liver enzymes in individuals with undiagnosed diabetes in the U.S.

Authors:  Christie Y Jeon; Christian K Roberts; Catherine M Crespi; Zuo-Feng Zhang
Journal:  J Diabetes Complications       Date:  2013-05-14       Impact factor: 2.852

2.  HIRREM™: a noninvasive, allostatic methodology for relaxation and auto-calibration of neural oscillations.

Authors:  Lee Gerdes; Peter Gerdes; Sung W Lee; Charles H Tegeler
Journal:  Brain Behav       Date:  2013-01-14       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.